March 4th 2023 Hilmar Warenius’ Patent on new lead agent ONKONEK filed by SYNTHERIX
June 7TH 2023 Peer reviewed new hypothesis about how cancer may first start published in Cancer Reports – Explains the way ONKONEK might be working.
hilmarwarenius
FURTHER NEWS FOR SYNTHERIX
Comments